These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 5926185)

  • 1. The effect of actinomycin D on post-phenobarbital activity of hepatic microsomal drug-metabolizing enzymes in the rat.
    Wilson JT; Fouts JR
    J Biol Chem; 1966 Oct; 241(20):4810-2. PubMed ID: 5926185
    [No Abstract]   [Full Text] [Related]  

  • 2. Some in vitro assay conditions that affect detection and quantitation of phenobarbital-induced increases in hepatic microsomal drug-metabolizing enzyme activity.
    Fouts JR
    Toxicol Appl Pharmacol; 1970 Jan; 16(1):48-65. PubMed ID: 4906675
    [No Abstract]   [Full Text] [Related]  

  • 3. Time course differences in the metabolism of drugs by hepatic microsomes from rats, rabbits and mice.
    Gram TE; Fouts JR
    J Pharmacol Exp Ther; 1966 Jun; 152(3):363-71. PubMed ID: 5922307
    [No Abstract]   [Full Text] [Related]  

  • 4. Phenobarbital-induced synthesis of the microsomal drug-metabolizing enzyme system and its relationship to the proliferation of endoplasmic membranes. A morphological and biochemical study.
    Orrenius S; Ericsson JL; Ernster L
    J Cell Biol; 1965 Jun; 25(3):627-39. PubMed ID: 4378769
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The inhibitory effect of aureomycin (chlortetracycline) pretreatment on some rat liver microsomal enzyme activities.
    Peters MA; Fouts JR
    Biochem Pharmacol; 1969 Jun; 18(6):1511-7. PubMed ID: 4389700
    [No Abstract]   [Full Text] [Related]  

  • 6. Possible role of P-450 in the oxidation of drugs in liver microsomes.
    Kato R
    J Biochem; 1966 Jun; 59(6):574-83. PubMed ID: 4381416
    [No Abstract]   [Full Text] [Related]  

  • 7. Differences in the oxidative metabolism of drugs by liver microsomes.
    Kato R; Takayanagi M; Oshima T
    Jpn J Pharmacol; 1969 Mar; 19(1):53-62. PubMed ID: 5306221
    [No Abstract]   [Full Text] [Related]  

  • 8. Hepatic microsomal activities in rats with long and short sleeping times after hexobarbital: a comparison.
    Mitoma C; Neubauer SE; Badger NL; Sorich TJ
    Proc Soc Exp Biol Med; 1967 May; 125(1):284-8. PubMed ID: 6027543
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of pretreatment of rabbits with phenobarbital or 3-methylcholanthrene on the distribution of drug-metabolizing enzyme activity in subfractions of hepatic microsomes.
    Gram TE; Rogers LA; Fouts JR
    J Pharmacol Exp Ther; 1967 Aug; 157(2):435-45. PubMed ID: 6039834
    [No Abstract]   [Full Text] [Related]  

  • 10. Stress-induced alterations in microsomal drug metabolism in the adrenalectomized rat.
    Furner RL; Stitzel RE
    Biochem Pharmacol; 1968 Jan; 17(1):121-7. PubMed ID: 5638546
    [No Abstract]   [Full Text] [Related]  

  • 11. Influence of age and diet on the induction of hexobarbital-metabolizing enzymes in the mouse.
    Hospador MA; Manthei RW
    Proc Soc Exp Biol Med; 1968 May; 128(1):130-2. PubMed ID: 4385350
    [No Abstract]   [Full Text] [Related]  

  • 12. Comparison of hepatic drug-metabolizing enzymes induced by 3-methylcholanthrene and phenobarbital between pre- and postnatal rats.
    Sunouchi M; Takanaka A; Mizokami K; Inoue K; Fujimori K; Kasuya Y; Omori Y
    Toxicol Appl Pharmacol; 1984 May; 73(3):457-63. PubMed ID: 6326348
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [On the activation of dopa decarboxylase and other cytoplasmic liver enzymes by inducers of microsomal enzymes].
    Palm D; Ernzerhoff C; Holtz P
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1967; 258(4):352-71. PubMed ID: 4174080
    [No Abstract]   [Full Text] [Related]  

  • 14. Hepatic drug-metabolizing enzyme activity in rats pretreated with (-)-emetine or (plus or minus)-2,3-dehydroemetine.
    Miller HH; Johnson RK; Donahue JD; Jondorf WR
    Biochem J; 1970 Apr; 117(3):491-8. PubMed ID: 4392930
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of hepatic microsomal enzymes by alkylating agents.
    Tardiff RG; Dubois KP
    Arch Int Pharmacodyn Ther; 1969 Feb; 177(2):445-56. PubMed ID: 5807177
    [No Abstract]   [Full Text] [Related]  

  • 16. The effect of chronic phenobarbital administration on some hepatic drug-metabolizing enzyme activities in the rat.
    Wilson JT; Fouts JR
    Biochem Pharmacol; 1966 Aug; 15(8):1238-41. PubMed ID: 5973166
    [No Abstract]   [Full Text] [Related]  

  • 17. Influence of partial hepatectomy on the induction of liver microsomal drug-metabolizing enzymes produced by phenobarbital. A biochemical and ultrastructural study.
    Chiesara E; Conti F; Meldolesi J
    Lab Invest; 1970 Apr; 22(4):329-38. PubMed ID: 5429533
    [No Abstract]   [Full Text] [Related]  

  • 18. Further observations on hepatic drug metabolism in rats treated with a mixture of somatotropin, corticotropin and prolactin.
    Wilson JT
    Life Sci; 1969 Oct; 8(19):1095-102. PubMed ID: 4310843
    [No Abstract]   [Full Text] [Related]  

  • 19. Microsomal metabolism of the hepatotoxin -naphthylisothiocyanate (ANIT) following phenobarbital, chlorpromazine or actinomycin D treatment.
    Roberts RJ
    Proc Soc Exp Biol Med; 1973 Jan; 142(1):365-7. PubMed ID: 4683260
    [No Abstract]   [Full Text] [Related]  

  • 20. The effect of ethchlorvynol on the drug-metabolizing enzymes of rats and dogs.
    Martin YC
    Biochem Pharmacol; 1967 Oct; 16(10):2041-4. PubMed ID: 4169212
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.